ACC/AHA血压指南与ADA糖尿病高血压立场声明在糖尿病成人中的一致性比较
该研究基于NHANES 2011-2016数据,分析美国糖尿病成人中ACC/AHA指南与ADA立场声明在高血压患病率和降压治疗推荐上的一致性。结果显示两种标准下高血压患病率分别为77.1%和66.3%,一致性89.2%;未用药者启动治疗推荐总体一致性75.2%,已用药者血压达标状态一致性95.7%。
要点
- ACC/AHA与ADA定义下糖尿病成人高血压患病率分别为77.1%和66.3%,一致性89.2%。
- 未用降压药者中,两文档均不推荐启动治疗者占52.8%,均推荐者占22.4%。
- 已用降压药者中,两文档均未达标者占45.3%,均达标者占50.4%。
核心结论
- 高比例的美国糖尿病成人被ACC/AHA血压指南和ADA糖尿病高血压立场声明给予相同的降压治疗推荐。
研究设计与样本
- 基于美国NHANES 2011-2016数据,纳入2,266名糖尿病成人,比较ACC/AHA指南与ADA立场声明在高血压患病率和降压治疗推荐上的一致性。
主要发现
- 高血压患病率(95%CI)按ACC/AHA定义为77.1%(73.9, 80.0),按ADA定义为66.3%(63.4, 69.1)。
- 两种定义均无高血压者占22.9%(20.0, 26.1),高血压状态一致性为89.2%(87.2, 91.0)。
- 未用降压药者中,两文档均不推荐启动治疗者占52.8%(47.7, 57.8),均推荐者占22.4%(19.2, 25.9),总体一致性75.2%(70.4, 79.4)。
- 已用降压药者中,两文档均未达标者占45.3%(41.3, 49.4),均达标者占50.4%(46.5, 54.2),总体一致性95.7%(93.4, 97.2)。
临床怎么用
- 在临床实践中,对于美国糖尿病成人,ACC/AHA血压指南与ADA立场声明在降压治疗推荐上具有较高一致性。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine the concordance in the prevalence of hypertension and pharmacological antihypertensive treatment recommendations for U.S. adults with diabetes using definitions from the 2017 American College of Cardiology/American Heart Association (ACC/AHA) blood pressure (BP) guideline and the 2017 American Diabetes Association (ADA) diabetes and hypertension position statement. RESEARCH DESIGN AND METHODS: We analyzed data for U.S. adults with diabetes in the U.S. National Health and Nutrition Examination Survey (NHANES), 2011-2016 (n = 2,266). Diabetes was defined by treatment with glucose-lowering medication, glycosylated hemoglobin ≥6.5%, fasting serum glucose ≥126 mg/dL, or nonfasting serum glucose ≥200 mg/dL. BP was measured three times and antihypertensive medication use was self-reported. RESULTS: The prevalence (95% CI) of hypertension among U.S. adults with diabetes was 77.1% (73.9, 80.0) and 66.3% (63.4, 69.1) according to the ACC/AHA and ADA definitions, respectively. Also, 22.9% (20.0, 26.1) did not have hypertension according to either definition, and the concordance in hypertension status was 89.2% (87.2, 91.0). Among U.S. adults with diabetes not taking antihypertensive medication, 52.8% (47.7, 57.8) were not recommended to initiate antihypertensive medication by either the ACC/AHA or the ADA document and 22.4% (19.2, 25.9) were recommended to initiate it by both documents (overall concordance 75.2% [70.4, 79.4]). Among those taking antihypertensive medication, 45.3% (41.3, 49.4) and 50.4% (46.5, 54.2) had BP above the goal in neither and both documents, respectively (overall concordance 95.7% [93.4, 97.2]). CONCLUSIONS: A high percentage of U.S. adults with diabetes are provided identical antihypertensive treatment recommendations by the ACC/AHA BP guideline and the ADA diabetes and hypertension position statement.
引用
- Muntner P, Whelton PK, Woodward M, et al. A Comparison of the 2017 American College of Cardiology/American Heart Association Blood Pressure Guideline and the 2017 American Diabetes Association Diabetes and Hypertension Position Statement for U.S. Adults With Diabetes. Diabetes Care. 2018. PMID: 30150235. doi:10.2337/dc18-1307
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。